ChloramphenicolThird Party Manufacturing in India

Chloramphenicol is a broad-spectrum bacteriostatic antibiotic that inhibits bacterial protein synthesis at the ribosomal level. It specifically and reversibly binds to the 50S ribosomal subunit of susceptible bacteria, interacting with the A2451 and A2452 residues in the 23S rRNA. This binding prevents the peptidyl transferase enzyme from catalysing peptide bond formation, effectively halting the elongation of the growing polypeptide chain.

Unlike macrolide antibiotics that physically block the peptide exit tunnel, chloramphenicol directly interferes with substrate binding at the peptidyl transferase centre. This mechanism is highly effective against a wide range of Gram-positive and Gram-negative bacteria, as well as rickettsiae, chlamydiae, and mycoplasmas. At higher concentrations, chloramphenicol can exert bactericidal activity against certain susceptible organisms such as Haemophilus influenzae.

The selectivity of chloramphenicol for bacterial ribosomes is not absolute. At therapeutic doses, it can also inhibit mitochondrial protein synthesis in mammalian cells, which is the basis for its dose-dependent bone marrow suppression. This effect is particularly pronounced in cells with high metabolic activity, such as bone marrow precursors. The drug is lipid-soluble and penetrates well into tissues and body fluids, including the cerebrospinal fluid, aqueous humour, and pleural cavities, making it valuable for treating infections in otherwise difficult-to-reach anatomical sites.

Therapeutic Uses

Chloramphenicol is reserved for serious bacterial infections where other, less toxic antibiotics are ineffective or contraindicated. Its clinical use has declined significantly due to the risk of dose-independent aplastic anaemia, but it remains an important reserve antibiotic in specific indications:

• Typhoid fever and systemic Salmonella infections: Chloramphenicol was historically the gold standard for typhoid fever and remains useful against multi-drug resistant strains where alternative antibiotics are unavailable.
• Bacterial meningitis: Due to its excellent penetration into the cerebrospinal fluid, chloramphenicol is used for meningitis caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in patients with penicillin allergy.
• Brain abscess: Its ability to cross the blood-brain barrier makes it valuable for treating cerebral abscesses caused by anaerobic and mixed bacterial flora.
• Rickettsial infections: Effective against scrub typhus, Rocky Mountain spotted fever, and other rickettsial diseases, particularly in pregnant women where tetracyclines are contraindicated.
• Ophthalmic infections: Topical chloramphenicol preparations are widely used for bacterial conjunctivitis and keratitis due to their broad spectrum and good ocular penetration.
• Anaerobic infections: Active against Bacteroides fragilis and other anaerobes, useful in intra-abdominal infections and pelvic inflammatory disease.

Why Manufacturers Choose Chloramphenicol

Chloramphenicol remains a commercially important antibiotic for Indian manufacturers despite its restricted use profile. It is listed on the WHO Essential Medicines List and continues to be manufactured in large volumes for both domestic and export markets, particularly to African and Southeast Asian countries where it remains a frontline antibiotic due to its low cost and reliable supply chain.

The active pharmaceutical ingredient is well-established in Indian manufacturing, and tablet production requires standard equipment. Chloramphenicol is also a key ingredient in veterinary medicine formulations, which provides an additional and substantial market segment independent of human use restrictions.

This makes Chloramphenicol one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.